Upload others
View 1
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Interim Report H1/2019
New H1 2019 INDUSTRIAL AND WAREHOUSE REAL ESTATE MARKET · 2019. 7. 31. · H1 2019 INDUSTRIAL AND WAREHOUSE REAL ESTATE MARKET Saint Petersburg As at the end of H1 2019, nine properties
IMPROVED PROFITABILITY IN CHALLENGING …...37.1 47.9 H1/2019 47.2 9.3 13.3 H1/2020 107.5 0% North America +26% Nordics -6% Europe (excl. Nordics) +1% Other Regions -4% H1/2019 H1/2020
Biotest AG · Biotest Group: H1 2019 at a glance • Guidance 2019 confirmed • Sales of Continuing Operations in H1 2019 at €195.1 m vs. €200.7 m in H1 2018 • EBIT in H1 2019
Charter Court Financial Services Group PLC H1 2019 Results · H1 18 H1 19 25% 29% H1 18 H1 19 Performance Highlights –H1 2019 Underlying Operating Expense (£m) Cost of Risk2 (%)
H1FY2019 RESULTS PRESENTATION · 2019. 2. 18. · H1 FY15 H1 FY16 H1 FY15 H1 FY16 H1 FY19 RESULTS PRESENTATION H1 FY2019 8. OPERATING EXPENSES / OTHER INCOME OPEX: Decreased by 0.8%
H1 2019 Results - pbinvestmedia.s3.amazonaws.com · H1 15 H2 15 H1 16 H2 16 H1 17 H2 17 H1 18 H2 18 H1 19 (1)Excludes depreciation, amortisation, share based payments charge, aquisition
Half year fraud update 2019 - FINAL - UK Finance year... · 6 2019 Half year fraud update UK Finance AUTHORISED PUSH PAYMENT (APP) SCAMS: OVERALL H1 2018 H2 2018 H1 2019 H1 18/H1
Interim report H1 2019 - fs.dk
Half year results presentation - Auto Trader Group plc...132.7 144.1 155.9 H1 2018 H1 2019 H1 2020 1,674 1,826 1,951 H1 2018 H1 2019 H1 2020 13,213 13,153 13,316 H1 2018 H1 2019 H1
h1 - PayPay...2019/05/15 · Title h1 Created Date 9/18/2019 6:09:54 PM
Investor Presentation 2019 interim results · H1 2016. H2 2016. H1 2017. H2 2017. H1 2018. H2 2018. H1 2019. Single Managed. PSG Money Market. Segregated Institutional Portfolio*
2019 H1 RESULTS
H1 2019 Results - Lar España€¦ · Lar España Asset Appraisal 15 44.6% 13.6% 5.5% Since FY 2018 LfL H1 2019/18 Since Acquisition Total Portfolio H1 2019 Valuation €1,462 Mn
Q2 & H1 2019 Earnings Presentation
H1 · 2019. 4. 9. · Title: H1.pdf Created Date: 3/5/2019 11:11:09 AM
Dosage Calculation Using Ratio And Propo
H1 2019 Results and Project Update - highlandgold.com · H1 2019 Results Highlights Production at Mnogovershinnoye (MNV) in H1 2019 rose by 23.3% over the first half of last year
ACERINOX Q2 2020 RESULTS PRESENTATION · ACERINOX Q2 2020 RESULTS PRESENTATION H1 2019 H1 2020 Variation H1 2020/H1 2019 Net Sales 2,442 2,331 -5% Adjusted EBITDA (1) 186 179 -4%
Investor and Analyst Conference Call H1 2019» · Investor and Analyst Conference Call H1 2019» Increase of Adjusted EBITDA as expected 1,276 H1 2018 H1 2019 1,141 Adjusted EBITDA
Management presentation of H1 2019 results · 8 Segmental analysis Revenue Adj. EBITDA Net debt €m H1 2018 H1 2019 Variance % H1 2018 H1 2019 Variance % FY 2018 H1 2019 Variance
Stanbic IBTC Holdings PLC - The Vault...H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 22,135 22,849 41,035 40,169 39,310 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 Net Interest Income 41,718
IPO Watch Europe - PwC · 2019-07-09 · H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 H1 2015 H1 2016 H1 2017 H1 2018 H1 2019 Stadler Rail AG Industrials
Holtek Semiconductor Inc....2019/Q2 Operating Results Holtek Semiconductor Inc. Consolidated Income Statements-2019/H1 NT$ K 2019/H1 2018/H1 YOY Amount % …
Umicore 2019 H1 presentations · Umicore H1 2019 performance 7 Catalysis H1 2019 market context Strong headwinds in the automotive industry Global light-duty vehicle production contracted
Investor Presentation 2020 Interim Results · H1 2016. H2 2016. H1 2017. H2 2017. H1 2018. H2 2018. H1 2019. H2 2019. H1 2020. Single Managed. PSG Money Market. Segregated Institutional
PROPO TRANSMISSI LINE / - REST r- -OBUASI
H1 2019 RESULTS - Covivio
H1 2019 Financial Results - Tarkett · 2019-07-24 · H1 2019 highlights Reported sales up 7.2% Organic growth (1) up 1.3% in H1 2019 Selling prices holding up well Adjusted EBITDA
KONE H1 2019 · kone h1 2019 july 18, 2019 henrik ehrnrooth, president & ceo ilkka hara, cfo